Where the Money Goes

You Power Cures

Obliteride funding matters at Fred Hutch — and our generous sponsors ensure that 100% of every dollar you raise goes right to work. In the last 10 years, we’ve fueled new approaches for breast, colon, pancreatic and prostate cancer. Advanced new breakthroughs in immunotherapy and data science. Supported community partnerships to improve health. Sparked urgently needed leadership in the response to COVID-19 and other infectious diseases. And helped Fred Hutch attract the world’s top researchers and nurture their most innovative work. 

Our 2022 Funded Researchers

When you Obliteride, every dollar you raise goes directly to work. Meet the Fred Hutch scientists and research you support. 

Richard Adeyemi, DVM, PhD

Richard Adeyemi, DVM, PhD

Learning how cells fix their broken DNA to understand cancer origins and inform new therapies.

Daniel Blanco-Melo, PhD

Daniel Blanco-Melo, PhD

Understanding our immune response to new and evolving viruses to improve treatments for current and emerging threats.

Marie Bleakley, MD, PhD, MMSC

Marie Bleakley, MD, PhD, MMSC

Developing therapies that optimize the cancer-fighting power of immune T cells while reducing side effects.

Susan Bullman, PhD

Susan Bullman, PhD

Studying how a type of bacteria leads to aggressive colorectal cancer to better prevent and treat it.

Burcu Darst, PhD

Burcu F. Darst, PhD

Improving screening by identifying genetic and other risk factors for prostate cancer in diverse populations.

Scott Nicolas Furlan, MD

Scott Nicolas Furlan, MD

Learning how immune T cells behave during and after treatment to improve immune-based therapies for children.

George Georges, MD

George Georges, MD

Refining blood stem cell transplantation and testing it to treat severe autoimmune diseases.

Leslie Goo, PhD, MPH

Leslie Goo, PhD, MPH

Researching mosquito- and tick-borne flaviviruses, including dengue and Zika, that threaten people worldwide.

Michael C. Haffner, MD, PhD

Michael C. Haffner, MD, PhD

Linking cellular changes to different prostate tumor pathologies to enhance diagnosis.

Aakanksha Singhvi, PhD

Aakanksha Singhvi, PhD

Illuminating the role of glia, which form one-half of our brain cells, in Alzheimer’s and autism.

Nasa Sinnott-Armstrong, PhD

Nasa Sinnott-Armstrong, PhD

Distilling complex genetic and environmental factors to better predict disease risk.

Christina M. Termini, MM, PhD

Christina M. Termini, MM, PhD

Uncovering how blood stem cells repopulate the bone marrow after radiation and transplant.

Masumi Ueda Oshima, MD, MA

Masumi Ueda Oshima, MD, MA

Improving stem cell transplantation and follow-up to catch relapse early. 

Joshua Veatch, MD, PhD

Joshua Veatch, MD, PhD

Designing new immunotherapies that harness immune T cells to fight lung and skin cancers.

Bo Zhang, PhD

Bo Zhang, PhD

Harmonizing medical records and study data to recommend changes in disease diagnosis and public health measures. 

A Decade of Discovery (And Counting)

Since 2013, Obliteride funding has supported more than 200 projects and more than 85 world-leading researchers — kickstarting a wheel of innovation that leads to even more discoveries over time. Here are three examples:

Dr. Roland Strong

In 2017, we supported Dr. Roland Strong to improve cancer treatment by helping create a tool that identifies “targets” present in cancer cells, but not healthy cells. 

Dr. Aude Chapuis

Dr. Aude Chapuis, holder of the John C. and Karyl Kay Hughes Endowed Chair, is not building on this work: retraining the body’s own immune cells to recognize targets and attack cancers.

Dr. Jen Adair

With Obliteride funding, Dr. Jen Adair holder of the Fleischauer Family Endowed Chair in Gene Therapy Translation developed a groundbreaking technology to make gene therapies for cancer more accessible worldwide. 

Dr. Hootie Warren

Dr. Hootie Warren continues to help improve treatment around the world, especially in communities with limited access to care.

Dr. Johanna Lampe

With early funding from Obliteride, Dr. Johanna Lampe identified nutrients associated with cancer risk, unlocking new insights into diet and risk reduction.

Dr. Heather Greenlee

Now, Dr. Heather Greenlee is continuing to improve health and nutrition. Her website, Cook for Your Life, provides science-based recipes to reduce risk, address challenges during treatment, and more.

Obliteride Is for Everyone!

Have fun and help cure cancer faster.